Search research articles
Contact Us
Filters
Showing results (1191-1200 of 1,368) with videos related to
Page
of 137
Sort By:
Advanced Healthcare Materials
|
April 23, 2014
Gel scaffolds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesis
Sungsoo S Lee, Erin L Hsu, Marco Mendoza, et al.
Cancer Research
|
March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity
Linlin Sun, Chia-Wei Li, Ezra M Chung, et al.
Controlled Clinical Trials
|
March 11, 1998
Stroke prevention trial in sickle cell anemia
R J Adams, V C McKie, D Brambilla, et al.
Haematologica
|
January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li, Xinsheng Ju, Kenneth Lee, et al.
Nature Communications
|
November 3, 2025
Rational design of potent small-molecule SMARCA2/A4 degraders acting via the recruitment of FBXO22
Elisia Villemure, Tom Januario, Mingshuo Zeng, et al.
Nature Cell Biology
|
October 9, 2020
Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou, Rongce Zhao, Weiya Xia, et al.
American Journal of Hematology
|
March 28, 2019
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain
Marcus A Carden, David C Brousseau, Fahd A Ahmad, et al.
Nature Cell Biology
|
September 15, 2020
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou, Rongce Zhao, Weiya Xia, et al.
The New England Journal of Medicine
|
July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
Yutaka Niihara, Scott T Miller, Julie Kanter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 13, 2016
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
Xinsheng Ju, Pablo A Silveira, Wei-Hsun Hsu, et al.
Page
of 137
Search research articles
Search
Showing results (1191-1200 of 1,368) with videos related to
Sort By:
Page
of 137
Advanced Healthcare Materials
|
April 23, 2014
Gel scaffolds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesis
Sungsoo S Lee, Erin L Hsu, Marco Mendoza, et al.
Cancer Research
|
March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity
Linlin Sun, Chia-Wei Li, Ezra M Chung, et al.
Controlled Clinical Trials
|
March 11, 1998
Stroke prevention trial in sickle cell anemia
R J Adams, V C McKie, D Brambilla, et al.
Haematologica
|
January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li, Xinsheng Ju, Kenneth Lee, et al.
Nature Communications
|
November 3, 2025
Rational design of potent small-molecule SMARCA2/A4 degraders acting via the recruitment of FBXO22
Elisia Villemure, Tom Januario, Mingshuo Zeng, et al.
Nature Cell Biology
|
October 9, 2020
Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou, Rongce Zhao, Weiya Xia, et al.
American Journal of Hematology
|
March 28, 2019
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain
Marcus A Carden, David C Brousseau, Fahd A Ahmad, et al.
Nature Cell Biology
|
September 15, 2020
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou, Rongce Zhao, Weiya Xia, et al.
The New England Journal of Medicine
|
July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
Yutaka Niihara, Scott T Miller, Julie Kanter, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 13, 2016
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
Xinsheng Ju, Pablo A Silveira, Wei-Hsun Hsu, et al.
Page
of 137